GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity

Figure 2

The expression of GPM6B is negatively correlated with the clinical stage of prostate cancer. (a) Immunohistochemical staining of surgical specimens from 94 prostate cancer patients was performed. (b) Statistical analysis of the immunohistochemistry results. (c) Kaplan-Meier survival curves and the log-rank test were used to assess the effect of GPM6B expression on survival in patients with PCa using data from the TCGA database. (d) The effect of GPM6B expression on survival in patients with PCa was determined using data from the First Affiliated Hospital of Zhengzhou University.

(a)

(b)

(c)

(d)